2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
118
Neoplasms
110
Lung Neoplasms
65
Colorectal Neoplasms
52
Prostatic Neoplasms
46
Carcinoma, Non-Small-Cell Lung
46
Pancreatic Neoplasms
34
Melanoma
33
Ovarian Neoplasms
29
Neoplastic Cells, Circulating
29
Head and Neck Neoplasms
27
Uterine Cervical Neoplasms
23
Multiple Myeloma
20
Glioma
20
Colonic Neoplasms
20
Sarcoma
19
Carcinoma, Hepatocellular
19
Leukemia, Myeloid, Acute
18
Neoplasm Metastasis
17
Lymphoma
15
Glioblastoma
15
Esophageal Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
14
Hematologic Neoplasms
14
Leukemia
13
Endometrial Neoplasms
13
Myelodysplastic Syndromes
11
Kidney Neoplasms
11
Gastrointestinal Neoplasms
11
Carcinoma, Renal Cell
11
Interventions
Creatine
2
telitacicept
1
nicotinamide-beta-riboside
1
fludarabine
1
Testosterone
1
Telemedicine
1
Positron-Emission Tomography
1
Magnetic Resonance Imaging
1
Exercise Movement Techniques
1
Eicosapentaenoic Acid
1
Cyclophosphamide
1
Carnitine
1
Caloric Restriction
1
Blood Specimen Collection
1
Autogenic Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Muscle Weakness
×
Blood Specimen Collection
×
Clear all
NCT06002945
2024-12-10
EXPLORE-MG2
Yale University
Active not recruiting
400 enrolled